Jianming Qiu (仇佳明), Email: qjm0909 AT uchicago.edu

Jiaming is currently a research analyst in the Department of Human Genetics at the University of Chicago. Jiaming obtained his master's and bachelor's degrees from Jilin University in Mainland China. Jiaming’s previous research primarily focused on small molecular drugs that exhibit anti-inflammatory and antibacterial effects by inhibiting the NF-KB and Nck-N-WASP signaling pathways. Jiaming has a keen interest in cell biology and molecular biology, and his current work focuses on gene regulation in neurodevelopmental disorders.

Representative publications:

  1. Min Liu*, Chunjian Wu*, Rui Wang, Jiaming Qiu, Zhentao She, Jianan Qu, Jiang Xia. Modulating Liquid-Liquid Phase Separation of Nck Adaptor Protein against Enteropathogenic Escherichia coli Infection. ACS Cent Sci. 2023 Dec 14;9(12):2358-2368.

  2. Jiaming Qiu, Yunyu Nie, Yuan Zhao, Yu Zhang, Linting Li, Rui Wang, Miaomiao Wang, Sheng Chen, Jianhao Wang, Yong-Qiang Li, and Jiang Xia. Safeguarding intestine cells against enteropathogenic Escherichia coli by intracellular protein reaction, a preventive antibacterial mechanism. Proc Natl Acad Sci U S A, 2020 Mar 10;117(10):5260-5268.

  3. Jiaming Qiu, Qianchao Wu, Hongming Lv, Yang Li, Di Wang, Xiuzhi Wang, Li-jun Yu, Hai-hua Feng. Pretreatment with the compound asperuloside decreases acute lung injury via inhibiting MAPK and NF-κB signaling in a murine model. International Immunopharmacology, 2016 Feb;31:109-15.

  4.  Jiaming Qiu, Lijun Yu, Xingxing Zhang, Qianchao Wu, Di Wang, Xiuzhi Wang, Cheng Xia, Haihua Feng. Asiaticoside attenuates lipopolysaccharide-induced acute lung injury via down-regulation of NF-κB signaling pathway. International Immunopharmacology, 2015 May;26(1):181-7.

  5.  Qianchao Wu*, Hongyu Li*, Jiaming Qiu, Haihua Feng. Betulin protects mice from bacterial pneumonia and acute lung injury. Microbial Pathogenesis, 2014 Oct;75:21-8.